Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Director departure
CC transcript
|
|
ALBANY MOLECULAR RESEARCH INC (AMRI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. reports a 0% stake in Albany Molecular Research Inc. |
| 09/25/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/25/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/25/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/25/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/25/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/25/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/25/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/05/2017 |
SC 13D/A
| D'Ambra David reports a 0% stake in Albany Molecular Research, Inc. |
| 09/05/2017 |
SC 13D/A
| D AMBRA CONSTANCE M reports a 0% stake in Albany Molecular Research, Inc. |
| 09/05/2017 |
SC 13D/A
| Marth William S reports a 0% stake in Albany Molecular Research, Inc. |
| 09/05/2017 |
SC 13D/A
| 3-Gutiver, S.L. reports a 0% stake in Albany Molecular Research, Inc. |
| 09/05/2017 |
SC 13D/A
| D AMBRA THOMAS E reports a 0% stake in Albany Molecular Research, Inc. |
| 09/05/2017 |
4
| FINE MARGALIT (Executive Vice President, API) has filed a Form 4 on ALBANY MOLECULAR RESEARCH INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 2,318 shares
@ $0
Disposed/sold 23,543 shares
@ $21.75, valued at
$512.1k
Disposed/sold 21,725 options to buy
@ $18.41, valued at
$400k
|
|
| 09/05/2017 |
4
| Ladin Felicia I (SVP, Treasurer & CFO) has filed a Form 4 on ALBANY MOLECULAR RESEARCH INC|
Txns:
| Granted 4,993 shares
@ $0
Disposed/sold 63,568 shares
@ $21.75, valued at
$1.4M
Disposed/sold 75,000 options to buy
@ $16.7, valued at
$1.3M
Disposed/sold 19,078 options to buy
@ $17.05, valued at
$325.3k
Disposed/sold 31,609 options to buy
@ $15.77, valued at
$498.5k
Disposed/sold 46,791 options to buy
@ $18.41, valued at
$861.4k
|
|
| 09/05/2017 |
4
| Hagen Steven R (SVP Manufacturing & Pharmaceut) has filed a Form 4 on ALBANY MOLECULAR RESEARCH INC|
Txns:
| Granted 3,138 shares
@ $0
Disposed/sold 43,655 shares
@ $21.75, valued at
$949.5k
Disposed/sold 3,750 options to buy
@ $2.93, valued at
$11k
Disposed/sold 7,500 options to buy
@ $5.99, valued at
$44.9k
Disposed/sold 3,750 options to buy
@ $5.99, valued at
$22.5k
Disposed/sold 20,000 options to buy
@ $10.43, valued at
$208.6k
Disposed/sold 16,280 options to buy
@ $17.05, valued at
$277.6k
Disposed/sold 22,889 options to buy
@ $15.77, valued at
$361k
Disposed/sold 29,412 options to buy
@ $18.41, valued at
$541.5k
|
|
| 09/05/2017 |
4
| OCONNOR KEVIN (Director) has filed a Form 4 on ALBANY MOLECULAR RESEARCH INC|
Txns:
| Disposed/sold 58,275 shares
@ $21.75, valued at
$1.3M
Disposed/sold 5,000 options to buy
@ $13.54, valued at
$67.7k
Disposed/sold 5,000 options to buy
@ $9.19, valued at
$46k
Disposed/sold 10,000 options to buy
@ $8.81, valued at
$88.1k
Disposed/sold 10,000 options to buy
@ $6.15, valued at
$61.5k
Disposed/sold 10,000 options to buy
@ $5.28, valued at
$52.8k
Disposed/sold 10,000 options to buy
@ $2.59, valued at
$25.9k
Disposed/sold 12,367 options to buy
@ $5.99, valued at
$74.1k
Disposed/sold 7,201 options to buy
@ $10.43, valued at
$75.1k
Disposed/sold 6,881 options to buy
@ $17.05, valued at
$117.3k
Disposed/sold 6,540 options to buy
@ $15.77, valued at
$103.1k
|
|
| 09/05/2017 |
4
| NAPOLITANO FERNANDO (Director) has filed a Form 4 on ALBANY MOLECULAR RESEARCH INC|
Txns:
| Disposed/sold 3,802 shares
@ $21.75, valued at
$82.7k
Disposed/sold 9,358 options to buy
@ $18.41, valued at
$172.3k
|
|
| 09/05/2017 |
4
| Deming David H (Director) has filed a Form 4 on ALBANY MOLECULAR RESEARCH INC|
Txns:
| Disposed/sold 6,838 shares
@ $21.75, valued at
$148.7k
Disposed/sold 9,358 options to buy
@ $18.41, valued at
$172.3k
|
|
| 09/05/2017 |
4
| Gutierrez Fuentes Luis Gerardo (Director) has filed a Form 4 on ALBANY MOLECULAR RESEARCH INC|
Txns:
| Disposed/sold 6,656 shares
@ $21.75, valued at
$144.8k
Disposed/sold 2,200,000 shares
@ $21.75, valued at
$47.9M
Disposed/sold 6,540 options to buy
@ $15.77, valued at
$103.1k
Disposed/sold 9,358 options to buy
@ $18.41, valued at
$172.3k
|
|
| 09/05/2017 |
4
| HAGEN KENNETH PAUL (Director) has filed a Form 4 on ALBANY MOLECULAR RESEARCH INC|
Txns:
| Disposed/sold 6,838 shares
@ $21.75, valued at
$148.7k
Disposed/sold 9,358 options to buy
@ $18.41, valued at
$172.3k
|
|
| 09/05/2017 |
4
| MADDALUNA ANTHONY J (Director) has filed a Form 4 on ALBANY MOLECULAR RESEARCH INC|
Txns:
| Disposed/sold 11,210 shares
@ $21.75, valued at
$243.8k
Disposed/sold 6,540 options to buy
@ $15.77, valued at
$103.1k
Disposed/sold 9,358 options to buy
@ $18.41, valued at
$172.3k
|
|
| 09/05/2017 |
4
| D AMBRA THOMAS E (Director) has filed a Form 4 on ALBANY MOLECULAR RESEARCH INC|
Txns:
| Gifted 23,050 shares
@ $0
Gifted 11,100 shares
@ $0
Gifted 2,400 shares
@ $0
Gifted 2,000 shares
@ $0
Gifted 46,200 shares
@ $0
Disposed/sold 2,393,339 shares
@ $21.75, valued at
$52.1M
Disposed/sold 20,000 options to buy
@ $2.93, valued at
$58.6k
Disposed/sold 20,000 options to buy
@ $5.99, valued at
$119.8k
Disposed/sold 7,201 options to buy
@ $10.43, valued at
$75.1k
Disposed/sold 6,881 options to buy
@ $17.05, valued at
$117.3k
Disposed/sold 6,540 options to buy
@ $15.77, valued at
$103.1k
|
|
| 09/05/2017 |
4
| CONWAY CHRISTOPHER M. (SVP, Discovery and Development) has filed a Form 4 on ALBANY MOLECULAR RESEARCH INC|
Txns:
| Granted 2,247 shares
@ $0
Disposed/sold 47,477 shares
@ $21.75, valued at
$1M
Disposed/sold 33,670 options to buy
@ $2.29, valued at
$77.1k
Disposed/sold 20,833 options to buy
@ $10.43, valued at
$217.3k
Disposed/sold 12,591 options to buy
@ $17.05, valued at
$214.7k
Disposed/sold 21,799 options to buy
@ $15.77, valued at
$343.8k
Disposed/sold 21,056 options to buy
@ $18.41, valued at
$387.6k
|
|
| 09/05/2017 |
4
| Svokos George (COO) has filed a Form 4 on ALBANY MOLECULAR RESEARCH INC|
Txns:
| Granted 6,064 shares
@ $0
Disposed/sold 129,150 shares
@ $21.75, valued at
$2.8M
Disposed/sold 100,000 options to buy
@ $10.25, valued at
$1M
Disposed/sold 29,167 options to buy
@ $10.43, valued at
$304.2k
Disposed/sold 19,078 options to buy
@ $17.05, valued at
$325.3k
Disposed/sold 42,145 options to buy
@ $15.77, valued at
$664.6k
Disposed/sold 56,818 options to buy
@ $18.41, valued at
$1M
|
|
| 09/05/2017 |
4
| BOYER MILTON (SVP, Drug Product Manufacturin) has filed a Form 4 on ALBANY MOLECULAR RESEARCH INC|
Txns:
| Granted 3,199 shares
@ $0
Disposed/sold 42,109 shares
@ $21.75, valued at
$915.9k
Disposed/sold 12,591 options to buy
@ $17.05, valued at
$214.7k
Disposed/sold 16,349 options to buy
@ $15.77, valued at
$257.8k
Disposed/sold 29,980 options to buy
@ $18.41, valued at
$551.9k
|
|
| 09/05/2017 |
4
| HENDERSON LORI M. (SVP, Secretary & Gen Counsel) has filed a Form 4 on ALBANY MOLECULAR RESEARCH INC|
Txns:
| Gifted 9,857 shares
@ $0
Granted 4,722 shares
@ $0
Disposed/sold 66,717 shares
@ $21.75, valued at
$1.5M
Disposed/sold 50,000 options to buy
@ $4.87, valued at
$243.5k
Disposed/sold 17,500 options to buy
@ $5.25, valued at
$91.9k
Disposed/sold 4,375 options to buy
@ $2.93, valued at
$12.8k
Disposed/sold 17,500 options to buy
@ $2.93, valued at
$51.3k
Disposed/sold 4,375 options to buy
@ $5.99, valued at
$26.2k
Disposed/sold 17,500 options to buy
@ $5.99, valued at
$104.8k
Disposed/sold 29,167 options to buy
@ $10.43, valued at
$304.2k
Disposed/sold 22,893 options to buy
@ $17.05, valued at
$390.3k
|
|
| 09/05/2017 |
4
| Marth William S (President and CEO) has filed a Form 4 on ALBANY MOLECULAR RESEARCH INC|
Txns:
| Disposed of 18,472 shares
@ $0
Disposed of 20,383 shares
@ $0
Disposed/sold 483,033 shares
@ $21.75, valued at
$10.5M
Disposed/sold 54,498 options to buy
@ $15.77, valued at
$859.4k
Disposed/sold 133,690 options to buy
@ $18.41, valued at
$2.5M
|
|
| 08/31/2017 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 08/31/2017 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 08/31/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/31/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/31/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
|
|
|